Streetbeat News

Earnings

ACM

AECOM (NYSE:ACM) reported Q3 earnings of $0.94 per share, missing the analyst consensus estimate of $0.95 by 1.05 percent. However, the company's quarterly sales of $3.66 billion beat the analyst consensus estimate of $3.49 billion by 4.93 percent.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:09 pm

HEAR

Turtle Beach (NASDAQ:HEAR) reported Q2 losses of $(0.41) per share, missing the analyst consensus estimate of $(0.33) by 24.24%. The company also reported quarterly sales of $47.98 million, missing the analyst consensus estimate of $51.33 million by 6.52%. However, these figures represent an increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:09 pm

BYND

Beyond Meat expects FY23 revenues to be between $360M-$380M, lower than the estimated $388.04M. This represents a decrease of 9%-14% compared to 2022. The company also anticipates operating expenses to be $245M or less and capital expenditures to be between $20M-$25M. Despite previously aiming for cash flow positive operations in the second half of 2023, the company now believes this is unlikely due to greater than expected consumer and category headwinds.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:09 pm

MED

Medifast reported Q2 earnings of $2.77 per share, beating the analyst consensus estimate of $1.44 by 92.36%. However, this is a decrease from $3.42 per share from the same period last year. The company also reported quarterly sales of $296.19 million, beating the analyst consensus estimate of $253.47 million by 16.85%, but this is a 34.66% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:09 pm

CHGG

Chegg has projected its Q3 total net revenues to be between $151M and $153M, which is in line with the estimated $152.37M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:08 pm

TTOO

T2 Biosystems has projected its FY23 revenue to be between $9.5M and $10.5M, which is lower than the estimated $10.27M.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:08 pm

CARA

Cara Therapeutics reported Q2 losses of $(0.58) per share, missing the analyst consensus estimate of $(0.56) by 3.57%. This is a 625% decrease from the same period last year. However, the company's quarterly sales of $6.93 million beat the analyst consensus estimate of $6.49 million by 6.83%, despite a 69.86% decrease from last year.

Portfolio Pulse from vinayak@benzinga.com

August 07, 2023 | 8:08 pm

CHGG

Chegg (NYSE:CHGG) reported Q2 earnings of $0.28 per share, meeting analyst consensus. This is a 24.32% decrease from last year's earnings. Quarterly sales were $182.90M, beating the analyst consensus of $176.19M by 3.81%, but a 6.07% decrease from last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:08 pm

PLUS

ePlus (NASDAQ:PLUS) reported Q1 earnings of $1.41 per share, beating the analyst consensus estimate of $0.99 by 42.42%. This is a 42.42% increase from the same period last year. The company also reported quarterly sales of $574.17 million, beating the analyst consensus estimate of $487.55 million by 17.77%. This is a 25.27% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:08 pm

BYND

Beyond Meat reported Q2 losses of $(0.83) per share, missing the analyst consensus estimate of $(0.81) by 2.47%. The company also reported quarterly sales of $102.10 million, missing the analyst consensus estimate of $111.28 million by 8.25%. This represents a 45.75% increase in losses and a 30.56% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 8:08 pm